Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance Treatment: Post Hoc Analysis of a Phase 3 Trial

Author:Kern, Drew   Dashtipour, Khashayar   Aldred, Jason   Kimber, Thomas   Iansek, Robert   Kukreja, Pavnit   Bergmann, Lars   Fisseha, Nahome   Gupta, Resmi   Talapala, Saritha   Jeong, Anna   Fung, Victor   Lepetit, Vincent   

Session Name:S32: Movement Disorders: Trials  

Topic:Movement Disorders  

Program Number:S32.004  

Author Institution:University of Colorado Anschutz Medical Campus, Aurora, CO  Loma Linda University, Loma Linda, CA  Selkirk Neurology & Inland Northwest Research, Spokane, WA  Department of Neurology Unit, Royal Adelaide Hospital  Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia  Monash Health, Melbourne, Australia  AbbVie Inc., North Chicago, IL  AbbVie Inc., Ludwigshafen, Germany  Movement Disorders Unit, Westmead Hospital  Sydney Medical School, University of Sydney , Sydney, Australia  

A Phase 1 First-in-human Study to Investigate the Safety, Tolerability and Food Effect of ABBV-CLS-7262

Author:Cho, William   Jeong, Anna   Malik, Paul   Boiser, Joey   Huang, Xiu   Rosebraugh, Matthew   

Session Name:P6: General Neurology: New Treatments  

Topic:General Neurology  

Program Number:P6.002  

Author Institution:Calico Life Sciences, South San Francisco, CA  AbbVie, North Chicago, IL